Cargando…
Current Management of Cancer-associated Venous Thromboembolism: Focus on Direct Oral Anticoagulants
Cancer-associated venous thromboembolism (CAT) is a common complication associated with high morbidity and mortality. In accordance with major clinical trials comparing low-molecular-weight heparin (LMWH) with a vitamin K antagonist (VKA), LMWH is currently the standard treatment for CAT, owing to i...
Autores principales: | Kim, Sang-A, Yhim, Ho-Young, Bang, Soo-Mee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374546/ https://www.ncbi.nlm.nih.gov/pubmed/30787683 http://dx.doi.org/10.3346/jkms.2019.34.e52 |
Ejemplares similares
-
Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism
por: Yhim, Ho-Young, et al.
Publicado: (2014) -
Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016) -
Challenging issues in the management of cancer-associated venous thromboembolism
por: Yhim, Ho-Young
Publicado: (2022) -
Incidence of Venous Thromboembolism: The 3(rd) Korean Nationwide Study
por: Hwang, Hun-Gyu, et al.
Publicado: (2022) -
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
por: Masini, Marta, et al.
Publicado: (2023)